Technical Specifications
| Drug Composition | Pazopanib |
|---|---|
| Variant / Strength | 400 mg |
| Dosage Form / Type | Tablets |
| Product Benefits | Kidney cancer & Soft tissue sarcoma |
| Packaging Type | Bottle |
| Delivery Time | 7 - 15 Days, as per delivery location. |
| Country of Origin | Made in India |
| Export Destinations | USA, UK, UAE, Philippines, Thailand, Kenya, Nigeria, Germany, Canada, Mexico, and 65+ more countries |
| Export Route | Shipped via temperature-controlled international air courier with full customs documentation |
Pazopanib 400 mg Tablet, a protein kinase inhibitor, is employed to address kidney cancer and soft tissue sarcoma.
The prescribed dosage of Pazopanib 400 mg Tablet should be adhered to, as per the doctor's recommendation. Its usage should be continued as long as advised by the doctor, and the duration of treatment depends on individual needs and response to the therapy. Regular monitoring of blood pressure is advisable, as Pazopanib 400 mg Tablet has the potential to elevate blood pressure.
For women undergoing treatment, the use of effective contraception is crucial to prevent pregnancy throughout the treatment and one month after completing the medication course. If diarrhea persists, ample fluids should be consumed, and any persistent issues should be promptly reported to the doctor. Weight loss may occur, and consulting a dietitian or increasing food intake can help manage this side effect. Pazopanib 400 mg Tablet may also lead to changes in hair color and abnormal skin pigmentation. If these effects become bothersome, it is recommended to consult with the doctor.
